03-09-2010    

HOME
Quienes Somos
Programas
Lineas
Agenda
Formación
Convocatorias
Publicaciones
Enlaces
   | Plan Estratégico | Coordinadores | Cursos | Conferencias Electronicas | Actividades | Enlaces |

Symposium - Molecular markers in cancer therapy

Present use and future perspectives
CNIO, Madrid, November 27-29, 2006
Symposium - Molecular markers in cancer therapy
 
e-mail Enviar por e-mail
print Versión para imprimir

Información relacionada:
More info
 
 

Organisers
Montserrat Sánchez-Céspedes and Miguel Ángel Piris
Molecular Pathology Program, CNIO
Cancer therapy is quickly moving towards the design of novel and targeted drugs, and some of
them are already in routine cancer clinical care or clinical trials. The search for molecular markers
identifying patients that may benefit from these treatments is becoming an urgent priority, and an
exciting area of research. The Molecular markers in cancer therapy: Present Use and Future
Perspectives Symposium aims for the discussion of candidate mechanisms and markers of drug
resistance and therapeutic efficacy.


Sessions
Targeting receptors and signal transduction; Proteosome inhibitors, apoptosis and inflammation;
Epigenetic and transcriptional therapies, and DNA damaging agents and microtubules
Confirmed Speakers
J. Albanell, Hospital Clinic, Barcelona, Spain
B. Aggarwal, MD Anderson Cancer Center, Texas, USA
M. Barbacid, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain
A. Bardelli, University of Torino Medical Schoo,. Torino, Italy
J. Baselga, Vall d’ Hebron University Hospital, Barcelona, Spain
R. Bernards, Netherlands Cancer Institute, Amsterdam, The Netherlands.
R. Brown, Beatson Institute, Glasgow, UK
D. Chauhan, Dana-Farber Cancer Institute and Harvard Medical School, Boston USA
M. Esteller, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain
T. Fojo, National Cancer Institute, Bethesda, USA
G. García-Manero, MD Anderson Cancer Center, Texas, USA
M. Hidalgo, Johns Hopkins University School of Medicine, Baltimore, USA
J. Palacios, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain
M. A. Pierotti, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy
M. A. Piris, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain
L. Pusztai, UT MD Anderson Cancer Center, Houston, USA
R. Rosell, Catalan Institute of Oncology, Barcelona, Spain
M. Sanchez-Cespedes, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain
D. Sidransky, Johns Hopkins University, Baltimore, USA
J.C. Soria, Institut Gustave-Roussy, Paris, France
R. Stupp, University Hospital Lausanne, Lausanne, Switzerland
H. de The, Université de Paris, France
E.G. de Vries, University of Groningen, The Netherlands

Admin
© Copyright 2008
Webmaster - Diseño Web - Powered by Big Medium